Sensory Abnormalities of the Limbs, Trunk, and Face

Published on 12/04/2015 by admin

Filed under Neurology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 3 (1 votes)

This article have been viewed 6302 times

Chapter 28 Sensory Abnormalities of the Limbs, Trunk, and Face

Clinical evaluation of sensory deficits is inherently more difficult than evaluation of motor deficits because of the subjective nature of the examination. Despite the best efforts of the clinician to make the sensory examination as precise as possible, inconsistency in the patient’s responses is common, and the types of sensory abnormalities may differ greatly among patients. Nevertheless, identifying sensory deficits is important in localizing lesions.

Accurate localization begins with a foundation of detailed anatomy. Presence or absence of motor deficits are also aids to differentiating anatomical localization, so sensory data are always considered together with evidence of other neurological dysfunction.

Anatomy and Physiology

Spinal Cord Pathways

Sensory afferent information passes through the dorsal root ganglia to the dorsal horn of the spinal cord. Some of the axons pass through the dorsal horn without synapsing and ascend in the ipsilateral dorsal columns; these serve mainly joint position and touch sensations. Other axons synapse in the dorsal horns, and the second-order sensory neurons cross in the anterior white commissure of the spinal cord to ascend in the contralateral spinothalamic tract. Although this tract is best known for conduction of pain and temperature information, some non-nociceptive tactile sensation is conducted as well.

The dorsal column tracts ascend to the cervicomedullary junction, where axons from the leg synapse in the nucleus gracilis and axons from the arms synapse in the nucleus cuneatus. Fig. 28.1 shows the ascending pathways through the spinal cord to the brain.

Brain Pathways

Sensory Abnormalities

Sensory perception abnormalities are varied, and the pattern of symptoms often is a clue to diagnosis:

Patients often use the term numbness to mean any of a variety of symptoms. Strictly speaking, numbness is loss of sensation usually manifested as decreased sensory discrimination and elevated sensory threshold; these are negative symptoms. Some patients use the term numbness to mean weakness; others are referring to positive sensory symptoms such as dysesthesia and paresthesia.

Dysesthesia is an abnormal perception of a sensory stimulus, such as when pressure produces a feeling of tingling or pain. If large-diameter axons are mainly involved, the perception typically is tingling; if small-diameter axons are involved, the perception commonly is pain. Paresthesia is an abnormal spontaneous sensation similar in quality to dysesthesia. Dysesthesias and paresthesias usually are seen in localized regions of the skin affected by peripheral neuropathic processes such as polyneuropathy or mononeuropathy. These perceptual abnormalities also can be seen in patients with central conditions such as myelopathy or cerebral sensory tract dysfunction.

Neuropathic pain can result from damage of any cause to the sensory nerves. Peripheral neuropathic conditions result in failure of conduction of the sensory fibers, giving decreased sensory function plus pain from discharge of damaged nociceptive axons. The pathophysiology of neuropathic pain is interesting. Part of its basis is lowering of the membrane potential of the axons so that minor deformation of the nerve can produce repetitive action-potential discharges (Zimmermann, 2001). An additional feature with neuropathic conditions appears to be membrane potential instability, so that the crests of fluctuations of membrane potential can produce action potentials. Finally, cross-talk (ephaptic transmission) between damaged axons allows an action potential in one nerve fiber to be abnormally transmitted to an adjacent nerve fiber. These pathophysiological changes also produce exaggerated sensory symptoms including hyperesthesia and hyperpathia. Hyperesthesia is increased sensory experience with a stimulus. Hyperpathia is augmented painful sensation.

Sensory ataxia is the difficulty in coordination of a limb that results from loss of sensory input, particularly proprioceptive input. The resulting deficit may resemble cerebellar ataxia, but other signs of cerebellar dysfunction are seen on neurological examination.

Localization of Sensory Abnormalities

A general guide to sensory localization is presented in Table 28.3. Guidelines for diagnosis of these sensory abnormalities are summarized in Table 28.4. Details of specific sensory levels of dysfunction are discussed next.

Table 28.3 Sensory Localization

Level of Lesion Features and Location of Sensory Loss
Cortical Sensory loss in contralateral body restricted to portion of the homunculus affected by lesion. If entire side is affected (with large lesions), either the face and arm or the leg tends to be affected to a greater extent.
Internal capsule Sensory symptoms in contralateral body which usually involve head, arm, and leg to an equal extent. Motor findings common, although not always present.
Thalamus Sensory symptoms in contralateral body including head. May split midline. Sensory dysfunction without weakness highly suggestive of lesion of the thalamus.
Spinal transaction Sensory loss at or below a segmental level, which may be slightly different for each side. Motor examination also key to localization.
Spinal hemisection Sensory loss ipsilateral for vibration and proprioception (dorsal columns), contralateral for pain and temperature (spinothalamic tract).
Nerve root Sensory symptoms follow dermatomal distribution.
Plexus Sensory symptoms span two or more adjacent root distributions, corresponding to anatomy of plexus divisions.
Peripheral nerve Distribution follows peripheral nerve anatomy or involves nerves symmetrically.

Peripheral Sensory Lesions

Lesions of peripheral nerves and the plexuses produce sensory loss that follows their peripheral anatomical distribution. Exact mapping of sensory deficit is commonly difficult because sensory testing is subjective. Also recognized are interindividual differences in sensory peripheral anatomy including distribution and overlap of sensory fields. Peripheral sensory loss produces a multitude of potential complaints. Clues to localization are as follows:

Unfortunately, especially with peripheral lesions, a discrepancy between the complaint and the examination findings is common. The patient may complain of sensory loss affecting an entire limb when the examination shows a median or ulnar distribution of sensory loss. Alternatively, the patient may complain of sensory loss, but examination fails to reveal a sensory deficit. This discrepancy is more likely to be due to limitations of the examination than to malingering. Also, patients may have significant sensory complaints as a result of pathophysiological dysfunction of the afferent axons while the integrity and conducting function of the axons are still intact, so the examination will show no loss of sensory function.

Fig. 28.2 summarizes the peripheral nerve anatomy of the body, and Fig. 28.3 shows the dermatomal distribution.

image

Fig. 28.3 Dermatomes: cervical (C), thoracic (T), lumbar (L), and sacral (S). Boundaries are not quite as distinct as shown here because of overlapping innervation and variability among individuals.

(Reprinted with permission from Martin, J.H., Jessell, T.M., 1991. Anatomy of the somatic sensory system. In: Kandel, E.R. (Ed.), Principles of Neural Science. Appleton & Lange, Norwalk, Conn.)

Spinal Sensory Lesions

Certain sensory syndromes suggest a spinal lesion:

Sensory level is a deficit below a certain level of the spinal cord segments. Dissociated sensory loss is disturbance of pain and temperature on one side of the body and of vibration and proprioception on the other side. The term also can be used to describe loss of one sensory modality (e.g., pain and temperature) with normality of the other sensory modality—in this instance, vibration and proprioception. Suspended sensory loss describes the clinical situation in which sensory loss involves a number of dermatomes while those above and below are spared. Sacral sparing is disturbance of sensory function in the legs, with preservation of perianal sensation.

Sensory Level

A spinal localization is suggested by loss of sensation below a certain spinal level (i.e., a sensory level). Loss of sensation in a myelopathic distribution without weakness and reflex abnormalities would be very unusual. Sensory symptoms with incipient myelopathy are more often positive than negative; the Lhermitte sign (electric shock–like paresthesias radiating down the spine and often into the arms and legs, produced by flexion of the cervical spine) is a common presentation of cervical myelopathy. Although the Lhermitte sign commonly is thought of as being associated with inflammatory conditions such as multiple sclerosis, it more commonly is seen with cervical spondylotic myelopathy and has been reported after radiation therapy affecting the cervical spinal cord and also even after cervical injections.

Although a spinal cord localization is suspected with a sensory level, the level of the sensory loss may be slightly different between the two sides; this finding does not indicate a second lesion. Also, a basic tenet of neurology for evaluation of spinal sensory levels is to look for a lesion not only at the upper level of the deficit but also higher. Magnetic resonance imaging (MRI) is the best noninvasive test for assessing sensory loss of spinal origin. Of note, demyelinating disease and other inflammatory conditions of the spinal cord may not be visualized on MRI, although if an inflammatory lesion is suspected, a contrasted study on a high-field scanner has greater diagnostic sensitivity (Runge, Muroff, and Jinkins, 2001).

Common Sensory Syndromes

Some common sensory syndromes are outlined in Table 28.5. Many of these are associated with motor deficits as well.

Peripheral Syndromes

Sensory Polyneuropathy

The most common presenting complaint among patients with distal symmetrical peripheral polyneuropathy is sensory disturbance. The disturbance can be negative (decreased discrimination and increased threshold) or positive (neuropathic pain, paresthesias, dysesthesias), or both. Most neuropathies involve motor and sensory fibers, although the initial symptoms usually are sensory.

Nerve conduction studies can evaluate the status of the myelin sheath, thereby identifying patients with predominantly demyelinating polyneuropathies, including acute inflammatory demyelinating polyneuropathy (AIDP) and chronic inflammatory demyelinating polyneuropathy (CIDP). Electromyography (EMG) can demonstrate denervation and hence axonal damage, thereby identifying the motor involvement of many neuropathies with predominantly axonal features (Misulis and Head, 2002).

Cerebrospinal fluid (CSF) study is rarely performed for isolated neuropathy, but in patients with autoimmune demyelinating neuropathies, it will show increased protein levels. Increased cellularity suggests an inflammatory cause.

Muscle biopsy usually is performed for evaluation of myopathy but in neuropathy may show denervation and reinnervation. Nerve biopsy can show several of the important causes of neuropathy including inflammatory infiltrates, segmental demyelination, amyloid deposition, and axonal dropout. Nerve and muscle biopsy should be left to those who have expertise in performing the procedure and interpreting the data.

Acquired Immunodeficiency Syndrome–Associated Neuropathies

Human immunodeficiency virus type 1 (HIV-1) infection can produce a variety of neuropathic presentations. One of the most common is a painful, predominantly sensory polyneuropathy (Robinson-Papp and Simpson, 2009). The diagnosis can be confirmed by nerve conduction studies, EMG, and the appropriate clinical findings. CSF analysis and biopsy usually are not necessary unless an HIV-1–associated vasculitis or infection (such as cytomegalovirus) is present.

Amyloid Neuropathy

Primary amyloidosis can produce a predominantly sensory neuropathy in approximately one third of affected patients (Simmons and Specht, 2010). Familial amyloid polyneuropathy is a dominantly inherited condition. Patients present with painful dysesthesias plus loss of pain and temperature sensation. Weakness develops later. Autonomic dysfunction is typical. Eventually the sensory loss can be severe enough to make the affected extremities virtually anesthetic. The diagnosis can be suspected on clinical grounds, and confirmation requires positive results on either DNA genetic testing or nerve biopsy. Findings on nerve conduction studies and the EMG are not specific.

Temperature-Dependent Sensory Loss

Leprosy can produce sensory deficits that predominantly affect cooler regions of the skin including the fingers, toes, nose, and ears (Wilder-Smith and Van Brakel, 2008). Temperature sensation initially is impaired, with subsequent involvement of pain and touch sensation in the cooler skin regions. The deficit gradually ascends to warmer areas, typically in a stocking-glove distribution, with frequent trigeminal and ulnar nerve involvement. The diagnosis of leprosy is suggested by these findings and can be confirmed by additional testing including assay for antibodies to phenolic glycolipid-I (PGL-I) and nerve biopsy.

Mononeuropathy

Of the many recognized mononeuropathies, the most common is carpal tunnel syndrome, with ulnar neuropathy a close second. Although not classically considered a mononeuropathy, radiculopathy can be considered to fall into this category because one peripheral nerve unit is affected.

Spinal Syndromes

Syringomyelia

Syringomyelia is the presence of a syrinx, or fluid-filled space, in the spinal cord that extends over several to many segments. This is most commonly associated with a Chiari malformation (Koyanagi and Houkin, 2010). The pathogenic theory is that partial obstruction to CSF flow plus pressure waves in the CSF result in rupture of the central canal into the parenchyma of the spinal cord, which then produces symptoms by mechanical effects. The mass effect of the syrinx produces damage to the fibers crossing in the anterior commissure that are destined for the spinothalamic tract, which conveys pain and temperature sensation. With more severe enlargement of the syrinx, damage to the surrounding ascending tracts may occur, affecting sensation below the level of the lesion. By the time this develops, segmental motoneuron damage and descending corticospinal tract damage are almost always present, and clinical signs of these changes can be seen.

Brain Syndromes

Functional (or Psychogenic) Sensory Loss

Functional sensory loss is less common than other positive functional neurological symptoms such as seizures or paralysis. In fact, it is easy to mistakenly ascribe a pattern of sensory loss to a nonanatomical cause when in fact true disease is present. Such misdiagnosis is particularly common with thalamic infarction and plexus dysfunction. Of note, embellished sensory or motor loss, although obvious to the examiner, may be superimposed on a real neurological deficit. The patient may be unintentionally helping the examiner yet essentially ruining the credibility of the report.

These cautionary notes should be borne in mind. In general, however, clinical presentations suggesting functional sensory loss include:

The discrepancies in total anesthesia can be failure to perceive any sensory stimulus on an extremity that moves perfectly well. This degree of sensory loss would be expected to produce sensory ataxia. Another trap for a patient with psychogenic anesthesia of a limb involves tapping the limb while the patient’s eyes are closed; consequent movement of the limb confirms the functional nature of the deficit. Third, if the anesthetic limb is an arm, examining for sensory abnormality while the arms are folded across the chest can be confusing for the malingering patient, especially if performed quickly.

References

Bland J.D. Carpal tunnel syndrome. Curr Opin Neurol. 2005;18:581-585.

Cut S. Cubital tunnel syndrome. Postgrad Med J. 2007;83:28-31.

Gutiérrez-Gutiérrez G., Sereno M., Miralles A., et al. Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clin Transl Oncol. 2010 Feb;12(2):81-91.

Hughes R.A., Cornblath D.R. Guillain-Barré syndrome. Lancet. 2005 Nov 5;366(9497):1653-1666.

Klit H., Finnerup N.B., Jensen T.S. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009 Sep;8(9):857-868.

Koyanagi I., Houkin K. Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis. Neurosurg Rev. 2010 Jul;33(3):271-284.

Marra C.M. Update on neurosyphilis. Curr Infect Dis Rep. 2009 Mar;11(2):127-134.

Misulis K.E., Head T.C. Essentials of Clinical Neurophysiology, third ed. Philadelphia: Elsevier; 2002.

Nicholson B.D. Evaluation and treatment of central pain syndromes. Neurology. 2004;62(Suppl. 2):30-36.

Robinson-Papp J., Simpson D.M. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve. 2009 Dec;40(6):1043-1053.

Rudnicki S.A., Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005;18:598-603.

Runge V.M., Muroff L.R., Jinkins J.R. Central nervous system: review of clinical use of contrast media. Top Magn Reson Imaging. 2001 Aug;12(4):231-263.

Simmons Z., Specht C.S. The neuromuscular manifestations of amyloidosis. J Clin Neuromuscul Dis. 2010 Mar;11(3):145-157.

Wilder-Smith E.P., Van Brakel W.H. Nerve damage in leprosy and its management. Nat Clin Pract Neurol. 2008 Dec;4(12):656-663.

Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol. 2001;429:23-37.